Clarithromycin Associated With Torsades de Pointes
- 1 January 1999
- journal article
- case report
- Published by Japanese Circulation Society in Japanese Circulation Journal
- Vol. 63 (5) , 421-422
- https://doi.org/10.1253/jcj.63.421
Abstract
Two cases of QT prolongation and torsades de pointes (TdP) are presented. The patients had been taking clarithromycin (400 mg/day) for respiratory disease. Although erythromycin is reportedly associated with TdP, this is the first report of clarithromycin associated with TdP in the absence of other drugs already known to produce QT prolongation. (Jpn Circ J 1999; 63: 421 - 422)Keywords
This publication has 7 references indexed in Scilit:
- Torsades de pointes in two chronic renal failure patients treated with Cisapride and ClarithromycinAmerican Journal of Kidney Diseases, 1997
- Cellular and Ionic Mechanisms Underlying Erythromycin-Induced Long QT Intervals and Torsade de PointesJournal of the American College of Cardiology, 1996
- Cisapride and Fatal ArrhythmiaNew England Journal of Medicine, 1996
- Erythromycin Monotherapy Associated with Torsade de PointesAnnals of Pharmacotherapy, 1996
- Probucol-induced QT prolongation and syncope.Japanese Circulation Journal, 1994
- Electrophysiological mechanisms in a canine model of erythromycin-associated long QT syndrome.Circulation, 1993
- Diagnostic criteria for the long QT syndrome. An update.Circulation, 1993